Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Tracking Consumables in Bioreactor Runs – V 2.0

Posted on By


Biosimilars: SOP for Tracking Consumables in Bioreactor Runs – V 2.0


Standard Operating Procedure for Tracking Consumables in Bioreactor Runs in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/116/2025
Supersedes SOP/BS/116/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for documenting, labeling, and verifying all consumables used during bioreactor runs in biosimilar upstream processing, ensuring traceability, quality control, and regulatory compliance.

2. Scope

This SOP applies to all single-use and reusable consumables such as filters, bags, tubing, gaskets, sensors, clamps, and sampling devices used during bioreactor preparation, inoculation, cultivation, and harvest operations in the upstream biosimilar facility.

3. Responsibilities

  • Production Operator: Record lot numbers and quantities of all consumables used.
  • Warehouse: Ensure only approved and released materials are issued.
  • QA: Verify reconciliation and traceability of consumables in the batch record.

4. Accountability

The Head of Production is accountable for ensuring consumable usage is traceable and properly documented for every bioreactor batch.

5. Procedure

5.1 Consumable Issuance

  1. Raise a requisition using internal request form (Annexure-1) specifying batch, bioreactor ID, and expected consumables.
  2. Warehouse issues items from approved stock, noting:
    • Item name
    • Part number
    • Lot number
    • Quantity
  3. Transfer issued materials to staging area in labeled transport containers.

5.2 Pre-Use Verification

  1. Operators to inspect and verify:
    • Packaging integrity
    • Labeling and lot no. against request
    • Expiry date and status of approval
  2. Record verifications in Annexure-2: Consumable Usage Log.

5.3 During Bioreactor Run

  1. Affix a color-coded tag or barcode to tubing sets, filters, bags after assembly.
  2. Record usage point (e.g., harvest line, feed port) in bioreactor checklist.
  3. Mark partial use of any item and transfer balance to labeled return bin.

5.4 Post-Run Reconciliation

  1. Cross-check used vs. issued quantity using Annexure-3.
  2. Return unopened consumables to warehouse with “Return to Stock” label.
  3. Dispose used consumables via bio-waste process; log in disposal section of Annexure-2.

5.5 Documentation and Review

  1. Submit complete records with batch manufacturing file for QA review.
  2. QA to verify consistency and completeness before batch release.

6. Abbreviations

  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • ID: Identification

7. Documents

  1. Consumable Requisition Form – Annexure-1
  2. Consumable Usage Log – Annexure-2
  3. Reconciliation Report – Annexure-3

8. References

  • WHO TRS 1003 – GMP for Biologics
  • EU GMP Part I and II – Traceability and Documentation Requirements

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Consumable Requisition Form

Batch No. Bioreactor ID Item Part No. Qty Requested By
BS-P001 BR-200L pH Probe PH4500 2 Sunita Reddy

Annexure-2: Consumable Usage Log

Date Item Lot No. Used Qty Remaining Disposed Operator
04/05/2025 0.2µm Filter F3821 1 0 Yes Ajay Verma

Annexure-3: Reconciliation Report

Item Issued Used Returned Disposed Verified By
Sampling Bag 10 8 2 0 QA Officer

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Expanded to include barcoding and reconciliation log System improvement
See also  Biosimilars: SOP for Shift Handover Procedures - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Analytical Method Development: Sample Handling in Microbiological Testing – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Sterility Testing of Injectable Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version